title: Differences in the nemosis response of normal and cancer-associated fibroblasts from patients with oral squamous cell carcinoma.
abstract: BACKGROUND
  Tumor-stroma reaction is associated with activation of fibroblasts. Nemosis is a novel type of fibroblast activation. It leads to an increased production of growth factors and proinflammatory and proteolytic proteins, while at the same time cytoskeletal proteins are degraded. Here we used paired normal skin fibroblasts and cancer-associated fibroblasts (CAF) and primary and recurrent oral squamous cell carcinoma (SCC) cells to study the nemosis response.
  
  
  RESULTS
  Fibroblast nemosis was analyzed by protein and gene expression and the paracrine regulation with colony formation assay. One of the normal fibroblast strains, FB-43, upregulated COX-2 in nemosis, but FB-74 cells did not. In contrast, CAF-74 spheroids expressed COX-2 but CAF-43 cells did not. Alpha-SMA protein was expressed in both CAF strains and in FB-74 cells, but not in FB-43 fibroblasts. Its mRNA levels were downregulated in nemosis, but the CAFs started to regain the expression. FSP1 mRNA was downregulated in normal fibroblasts and CAF-74 cells, but not in CAF-43 fibroblasts. Serine protease FAP was upregulated in all fibroblasts, more so in nemotic CAFs. VEGF, HGF/SF and FGF7 mRNA levels were upregulated to variable degree in nemosis. CAFs increased the colony formation of primary tumor cell lines UT-SCC-43A and UT-SCC-74A, but normal fibroblasts inhibited the anchorage-independent growth of recurrent UT-SCC-43B and UT-SCC-74B cells.
  
  
  CONCLUSIONS
  Nemosis response, as observed by COX-2 and growth factor induction, and expression of CAF markers alpha-SMA, FSP1 and FAP, varies between fibroblast populations. The expression of CAF markers differs between normal fibroblasts and CAFs in nemosis. These results emphasize the heterogeneity of fibroblasts and the evolving tumor-promoting properties of CAFs.
authors.affiliation: Haartman Institute, University of Helsinki, Helsinki, Finland. kati.rasanen@helsinki.fi
authors.forename: Kati
authors.initials: K
authors.lastname: Räsänen
authors.forename: Ismo
authors.initials: I
authors.lastname: Virtanen
authors.forename: Pertteli
authors.initials: P
authors.lastname: Salmenperä
authors.forename: Reidar
authors.initials: R
authors.lastname: Grenman
authors.forename: Antti
authors.initials: A
authors.lastname: Vaheri
mesh_terms: D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000378:metabolism / Q000503:physiopathology*; D045744:Cell Line, Tumor; D005260:Female; D005347:Fibroblasts / Q000166:cytology / Q000378:metabolism / Q000473:pathology*; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007249:Inflammation; D008297:Male; D009062:Mouth Neoplasms / Q000378:metabolism / Q000503:physiopathology*; D012008:Recurrence; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012867:Skin / Q000166:cytology / Q000473:pathology*